FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称NALTREXONE HYDROCHLORIDE
异名/同义词17-CYCLOPROPYLMETHYL)-4,5.ALPHA.-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE HYDROCHLORIDE
CONTRAVE COMPONENT NALTREXONE HYDROCHLORIDE
EMBEDA COMPONENT NALTREXONE HYDROCHLORIDE
EN-1639A
EN-1639A (AS HYDROCHLORIDE)
MORPHINAN-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXY-, HYDROCHLORIDE, (5.ALPHA.)-
NALTREXONE HCL
NALTREXONE HYDROCHLORIDE
NALTREXONE HYDROCHLORIDE [EP MONOGRAPH]
NALTREXONE HYDROCHLORIDE [GREEN BOOK]
NALTREXONE HYDROCHLORIDE [MART.]
NALTREXONE HYDROCHLORIDE [MI]
NALTREXONE HYDROCHLORIDE [ORANGE BOOK]
NALTREXONE HYDROCHLORIDE [USP MONOGRAPH]
NALTREXONE HYDROCHLORIDE [VANDF]
NALTREXONE HYDROCHLORIDE [WHO-DD]
REVIA
TREXAN
TROXYCA COMPONENT NALTREXONE HYDROCHLORIDE
CAS登记号16676-29-2
物质唯一标识(Unique Ingredient Identifier)Z6375YW9SF
分子式C20H23NO4.ClH
国际化合物标识(International Chemical Identifier,InChI)RHBRMCOKKKZVRY-ITLPAZOVSA-N
SMILES[C@]123[C@@]4([C@H](N(CC1)CC5CC5)Cc6c2c(c(O)cc6)O[C@]3(C(CC4)=O)[H])O.Cl
分子结构式
欧洲化学品管理局注册号(ECHA)240-723-0
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System